John Arena is interim president of global pharma services at Cencora, managing a team that offers a broad range of solutions ...

By embracing biohacking trends strategically and ethically, brands can position themselves as leaders in the wellness ...

Today, Uncle Sam’s foot is almost exclusively stomping on emerging biotechnology’s brakes, is only tepidly engaged with the accelerator, and is still hands off the wheel. A new Congress and ...

biotech ETFs offer a strategic investment option. Emerging biotech firms can be highly rewarding investments, but they also carry significant risk due to regulatory hurdles and market competition.

The emerging biotech's first commercial vaccine, for covid, received its first authorization in December 2020, and its early-stage pipeline and mRNA technology platforms have caught the eye of ...

Strategic investments in emerging biotech companies offer long-term upside, but also expose Innoviva to volatile swings in valuation that could compromise financial stability. Continuing to invest ...

India's bio-economy has witnessed an extraordinary 16-fold surge over the past decade, growing from $10 billion in 2014 to an ...